Medicare

Markets

Mylan Working to Finalize EpiPen Settlement

Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss.

Markets

3 Stupid Medicare Moves

Boneheaded moves can really set you back. Be smart about Medicare and you can improve both your physical and fiscal condition.